Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Simona Baculea"'
Autor:
Suzy Van Sanden, Ayman Youssef, Simona Baculea, Keith Stubbs, Spyros Triantos, Zijiao Yuan, Caitlin Daly
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 11, Iss 2 (2024)
**Background:** For patients with locally advanced or metastatic urothelial carcinoma (la/mUC), prognosis is poor and effective treatment options are limited. Erdafitinib is an oral fibroblast growth factor receptor (FGFR) kinase inhibitor approved b
Externí odkaz:
https://doaj.org/article/42643995ce534495b7548e8844af371b
Publikováno v:
Advances in Therapy
Introduction Ibrutinib (ibr) monotherapy and the combination of obinutuzumab plus chlorambucil (obi) are approved for previously untreated chronic lymphocytic leukemia (CLL). No trials directly comparing their efficacy are available. Therefore a matc
Autor:
Simona Baculea, Suzy Van Sanden, Sarah Cote, Kyle Fahrbach, Emily Dorman, Joris Diels, Yingxin Xu
Publikováno v:
Journal of comparative effectiveness research. 7(5)
Aim: A systematic literature review and network meta-analysis were conducted to determine the relative efficacy and safety of interventions for treatment-naive chronic lymphocytic leukemia patients, as comparative evidence is scarce. Materials & meth
Publikováno v:
Journal of medical economics. 20(10)
Chronic lymphocytic leukemia (CLL) is an orphan disease that primarily affects the elderly. The majority of symptomatic patients eligible for frontline treatment are unfit for fludarabine based chemoimmunotherapy. Historical treatment includes chlora
Publikováno v:
Management in Health. :7-10
Publikováno v:
Management in Health. :22-27
Publikováno v:
Alzheimer's & Dementia. 10
Community services On-site CGAT consultation 30.4 6 24.3 32.9 6 24.4 25.5 6 23.5 0.01 CGAT fast-track clinic 0.8 6 7.0 0.3 6 1.7 1.7 6 11.8 0.09 CVMO consultation 33.9 6 60.0 28.8 6 35.4 41.0 6 90.0 0.09 VMO consultation 4.7 6 17.4 5.2 6 18.4 3.9 6 1
Autor:
Eugeniu Turlea, Simona Baculea
Publikováno v:
Management in Health. :48-41